Alguna otra referencia:
(no te quejes, te las busco en español y todo)
Pérez Alvarez L, Villahermosa ML, Cuevas MT, Delgado E, Manjón N, Vázquez de Parga E, Medrano L, Contreras G, Thomson MM, Colomo C, Taboada JA, Nájera R and the Spanish Group for Antiretroviral Resistance Studies. Single and multidrug resistance mutations to reverse tran******ase and protease inhibitors human immunodeficiency bichito type1-infected patients from two geographical areas in Spain. J Hum Virol, 2000; 3(3):150-6.
Villahermosa ML, Thomson M, Vázquez de Parga E,.Cuevas MT, Contreras G, Pérez-Alvarez L, Delgado E, Manjón N, Medrano L and Nájera R. Improved conditions for extraction and amplification of human immunodeficiency bichito type 1 RNA from plasma samples with low viral load. J Hum Virol 2000; 3(1):27-34.
Pérez-Alvarez L, Cuevas MT, Villahermosa ML, Pedreira JD, Manjón N, Herrero I, López-alopécico S, Delgado E, Vázquez de Parga E, Medrano L, Thomson MM, Taboada JA, Nájera R and the Spanish Group for Antiretroviral Resistance Studies in Galicia. Prevalence of drug resistance mutations in B, non-B subtypes and recombinant forms of human immunodeficiency bichito type 1 in infected individuals in Spain (Galicia). J Hum Virol 2001; 4 (1):35-8.
Villahermosa ML, Beck I, Pérez-Alvarez L, Contreras G, Frenkel LM, Osmanov S, Vázquez de Parga E, Delgado E, Manjón N, Cuevas MT, Thomson MM, Medrano L and Nájera R. Detection and quantification of múltiple drug resistance mutations in HIV-1 reverse tran******ase by an oligonucleotide ligation assay. J Hum Virol 2001; 4 (5):238-48.
Pérez Alvarez L, Thomson MM, Villahermosa ML, Vázquez de Parga E, Rodríguez A, Cuevas MT, Delgado E, Manjón N, Miralles C, Medrano L, Taboada JA, Nájera R and the Spanish Group for Antiretroviral Resistance Studies in Galicia. HIV-1 subtype G and BG recombinant viruses in Spanish natives: evidence of characteristic mutations in reverse tran******ase and protesae. AIDS 2001; 15: 1907-15.
Ruibal-Brunet IJ, Cuevas MT, Díaz-Torres H, Villahermosa ML, Noa-Romero E, Vázquez de Parga E, Blanco de Armas M and Pérez Alvarez L. Genotypic resistance mutations to antiretroviral drugs in HIV-1 B and non-B subtypes from Cuba. Pan Am J Public Health 2001; 10(3): 174-9.
Delgado E, León-Ponte M, Villahermosa ML, Cuevas MT, Deibis L, Echeverría G, Thomson MM, Pérez-Alvarez L, Osmanov S and Nájera R. Analysis of HIV type 1 protease and reverse tran******ase sequences from Venezuela for drug resistance-associated mutations and subtype classification: A UNAIDS study.AIDS Res Hum Retroviruses 2001; 17(8):735-58.
Pérez-Alvarez L, Delgado E, Villahermosa ML, Cuevas MT, García V, Vázquez de Parga E, Thomson MM, Prieto A, Cuevas L, Medrano L, Taboada JA, Nájera R and the Spanish Group for Antiretroviral Resistance Studies in Galicia. Biological characteristics of newly described HIV-1 BG recombinants in Spanish individuals. AIDS 2002; 16: 669-72.
Villahermosa, M.L., Pérez-Alvarez, L., Vázquez de Parga, E., Cuevas, M.T. y Nájera, R. Resistencias del VIH a los antirretrovirales,. Virologia 2002;9:7-22.
Villahermosa ML, Pérez Alvarez L, Carmona R, Cuevas MT, Thomson MM., Medrano L, Vázquez de Parga E, Delgado E, Sierra M, Pedreira JD and Nájera R. Primary resistance mutations to fusion inhibitors and polymorphisms in gp41 sequences of HIV-1 non-B subtypes and recombinants. AIDS 2003;17:1083-1104.
Contreras G y Nájera R. Variabilidad genética de la infección por VIH en usuarios de drojas. Rev.Esp.Drogodependencias 2002;27:267-277.
Pérez-Alvarez L, Vázquez de Parga E, Carmona R, Muñoz M y Nájera R. drojas frente al bichito del SIDA. Mundo Científico 2003;245:50-55.
Pérez-Alvarez L,Vázquez de Parga E, Carmona R, Muñoz M y Nájera R. Resistencias de drojas en VIH. Mundo Científico 2003;245:56-61.
Pérez-Alvarez L, Carmona R, Muñoz M, Delgado E, Thomson MM, Contreras G, Pedreira JD, Rodríguez-Real R, Vázquez de Parga E, Medrano L, Taboada JA, Nájera R. and the Spanish Group for Antiretroviral Resistance Studies in Galicia. High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain. Study of genotypic resistance. Antiviral Therapy 2003;8:355-360.
Carmona R, Pérez-Alvarez L, Muñoz M, Casado G, Delgado E, Sierra M, Thomson M, Vega Y, Vázquez de Parga E, Contreras G, Medrano L, Nájera R. Natural resístanse-associated mutations to Enfuvirtide (T-20) and polymorphisms in the gp41 region of different HIV-1 genetic forms from T-20 naive patients. J.Clin.Virology. 2005;32:248-253.
Muñoz M, Carmona R, Pérez-Alvarez L, Cilla G, Suárez MD, Delgado E, Contreras G, Corra J, López de Goicoetxea MJ, Medrano L, Lezaún MJ, Nájera R. and the Spanish Group for Antiretroviral Resistance Studies in Basque Country. Análisis of discrepancies in the interpretation of antiretroviral drug resístanse results in HIV-1 infected patients of Basque Country, Spain. J. Clin.Virol. 2005;33:224-229.
Vega Y, Pérez-Alvarez L, Delgado E, Nájera R. Oligonucleotide ligation assay (OLA) for detection of point mutations associated with reverse tran******ase and protease inhibitors resistance in Human Immunodeficiency bichito type 1 (HIV-1) from non-B Subtypes and Recombinant Forms. J.Clin.Microbiol. 2005;43,10:5301-5304
Vázquez de Parga E, Rakhmanova A, Pérez-Alvarez L, Vinogradova A, Delgado E, Thomson MM, Casado G, Sierra M, Muñoz M, Carmona R, Vega Y, Contreras G, Medrano L, Osmanov S, Nájera R.Analysis of drug Resístance associated mutations in patients infected with different genetic forms of HIV-1 circulating in countries of the former Soviet Union. J.Med.Virol, 2005;77:337-344.
Pérez-Alvarez L, Carmona R, Ocampo A, Asorey A, Miralles C, Pérez de Castro S, Pinilla M, Contreras G, Taboada JA, Nájera R. Long-term monitoring of genotypic and phenotypic resístanse to T20 in treated HIV-1 infected patients. J.Med.Virol. Accepted for publication